Benjamin William Caulier
Postdoctoral Fellow
-
Centre for Cancer Cell Reprogramming
Norwegian version of this page
Username
Visiting address
Ullernchausséen 70
0379 Oslo
Postal address
Postboks 4950
0424 Oslo
My research project is focused on the development of an innovative anti-cancer modality, the Chimeric Antigen Receptor (CAR) therapy. This approach harnesses the potential of patients’ own immune cells to specifically kill their cancer. Practically, patients’ lymphocytes are modified with an innovative receptor (the CAR) to be redirected against a tumor antigen. The main goal of my project is to identify novel “targetable” antigens and develop innovative CAR designs to address the impediments of current CAR therapy especially against solid tumors.
Publications
-
Forcados, Christopher; Joaquina, Sandy; Casey, Nicholas Paul; Caulier, Benjamin William & Wälchli, Sébastien (2022). How CAR T cells breathe. Cells. ISSN 2073-4409. 11:1454(9), p. 1–16. doi: 10.3390/cells11091454.
-
Caulier, Benjamin William; Enserink, Jorrit & Wälchli, Sébastien (2021). Pharmacologic control of CAR T cells. International Journal of Molecular Sciences. ISSN 1661-6596. 22(9), p. 1–23. doi: 10.3390/ijms22094320. Full text in Research Archive
Published Apr. 7, 2021 3:45 PM
- Last modified Oct. 7, 2021 11:07 AM